Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

ENDRA Life Sciences Inc

NASDAQ NDRA
$4.27 0.0100 0.23%
Today share price
USA
Sector: Healthcare Industry: Diagnostics & Research
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 20 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
2.29M
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
347.31K
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
557.58K
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-31.79 %

Upcoming events ENDRA Life Sciences Inc

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart ENDRA Life Sciences Inc

Stock analysis ENDRA Life Sciences Inc

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-0.23 -0.44
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
0.49 1.06
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-0.04 -0.30
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.20 0.25
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-557.29 -48.60

Price change ENDRA Life Sciences Inc per year

3.09$ 14.63$
Min Max

Summary analysis ENDRA Life Sciences Inc

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure ENDRA Life Sciences Inc

Revenue and net income ENDRA Life Sciences Inc

All parameters

About company ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Address:
3600 Green Court, Ann Arbor, MI, United States, 48105-1570
Company name: ENDRA Life Sciences Inc
Issuer ticker: NDRA
ISIN: US29273B1044
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2017-05-09
Sector: Healthcare
Industry: Diagnostics & Research
Site: https://endrainc.com